Literature DB >> 15894979

Hypothermia is a bedside predictor of imminent death in patients with congestive heart failure.

Ward Casscells1, Moein F Vasseghi, Mir Said Siadaty, Mohammad Madjid, Hina Siddiqui, Birendra Lal, Saeed Payvar.   

Abstract

BACKGROUND: Most studies on predictors of mortality for patients with congestive heart failure (CHF) have described predictors that are either difficult to measure in routine practice or are only modestly sensitive and specific. Having observed 3 patients whose body temperature decreased shortly before death, we hypothesized that hypothermia may predict inhospital mortality.
METHODS: The medical records of 291 patients with a primary discharge diagnosis of CHF were selected from 423 admissions to Memorial Hermann Hospital, Houston, Tex, 1998, after excluding patients with comorbidities that confound body temperature, deaths for causes other than progressive pump failure, and readmissions except the last. Three groups were defined on the basis of admission body temperature (T adm): hypothermia groups T adm (95.5 degrees F-96.5 degrees F) and T adm < 95.5 degrees F, and reference group T adm > or = 96.6 degrees F. Several other known CHF risk factors were studied for confounding, and adjusted hazard ratios were calculated using Cox regression.
RESULTS: Of the 291 patients (mean age 73 years, 47% men), 17 (6%) had hypothermia on admission. Mean hospital stay was 5 days. Of the 17 (6%) patients who died of pump failure, 5 had been hypothermic on admission. Hypothermia was significantly associated with survival, and after adjusting for New York Heart Association functional class, hazard ratio for T adm < 95.5 degrees F was 4.46 (95% confidence interval 1.38-14.3) (P trend = .0283).
CONCLUSIONS: Hypothermia predicted inhospital death in these patients with CHF. If confirmed by future studies, this finding could prove useful, because temperature can be measured continuously, rapidly, and inexpensively, in or out of the hospital.

Entities:  

Mesh:

Year:  2005        PMID: 15894979     DOI: 10.1016/j.ahj.2004.07.038

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  Admission-to-discharge temperature reduction in decompensated heart failure is associated with rehospitalization.

Authors:  H R Omar; R Charnigo; M Guglin
Journal:  Herz       Date:  2017-09-05       Impact factor: 1.443

2.  Hepatic FGF21 preserves thermoregulation and cardiovascular function during bacterial inflammation.

Authors:  Sarah C Huen; Andrew Wang; Kyle Feola; Reina Desrouleaux; Harding H Luan; Richard Hogg; Cuiling Zhang; Qing-Jun Zhang; Zhi-Ping Liu; Ruslan Medzhitov
Journal:  J Exp Med       Date:  2021-08-18       Impact factor: 14.307

Review 3.  Devices in heart failure: potential methods for device-based monitoring of congestive heart failure.

Authors:  Shahzeb M Munir; Roberta C Bogaev; Ed Sobash; K J Shankar; Sreedevi Gondi; Igor V Stupin; Jillian Robertson; M Alan Brewer; S Ward Casscells; Reynolds M Delgado; Amany Ahmed
Journal:  Tex Heart Inst J       Date:  2008

4.  A mouse model of high trait anxiety shows reduced heart rate variability that can be reversed by anxiolytic drug treatment.

Authors:  Stefano Gaburro; Oliver Stiedl; Pietro Giusti; Simone B Sartori; Rainer Landgraf; Nicolas Singewald
Journal:  Int J Neuropsychopharmacol       Date:  2011-02-15       Impact factor: 5.176

5.  The Cardiopulmonary Effects of Sodium Fluoroacetate (1080) in Sprague-Dawley Rats.

Authors:  Bryan J McCranor; Talearia D Young; Justin Tressler; Laura Jennings; James Irwin; Nazira A Alli; Marilynda K Abilez; Samuel Stone; Michelle Racine; Jennifer L Devorak; Alfred M Sciuto; Benjamin Wong
Journal:  Cogent Biol       Date:  2019-01-31

6.  'Cold and Locked in': A Frozen Body and Frozen Eyes in End-Stage ALS.

Authors:  Boby V Maramattom
Journal:  Ann Indian Acad Neurol       Date:  2022-02-15       Impact factor: 1.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.